BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29889892)

  • 21. Polymorphic variation of hypoxia inducible factor-1 A (HIF1A) gene might contribute to the development of knee osteoarthritis: a pilot study.
    Fernández-Torres J; Hernández-Díaz C; Espinosa-Morales R; Camacho-Galindo J; Galindo-Sevilla Ndel C; López-Macay Á; Zamudio-Cuevas Y; Martínez-Flores K; Santamaría-Olmedo MG; Pineda C; Granados J; Martínez-Nava GA; Gutiérrez M; López-Reyes AG
    BMC Musculoskelet Disord; 2015 Aug; 16():218. PubMed ID: 26293784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WISP1 is a novel adipokine linked to inflammation in obesity.
    Murahovschi V; Pivovarova O; Ilkavets I; Dmitrieva RM; Döcke S; Keyhani-Nejad F; Gögebakan Ö; Osterhoff M; Kemper M; Hornemann S; Markova M; Klöting N; Stockmann M; Weickert MO; Lamounier-Zepter V; Neuhaus P; Konradi A; Dooley S; von Loeffelholz C; Blüher M; Pfeiffer AF; Rudovich N
    Diabetes; 2015 Mar; 64(3):856-66. PubMed ID: 25281430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma.
    Qiu M; Liu Y; Yu X; Qin L; Bei C; Zeng X; Qiu X; Tang B; He S; Yu H
    Tumour Biol; 2016 Mar; 37(3):3863-70. PubMed ID: 26476535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver intestine-cadherin (CDH17) haplotype is associated with increased risk of hepatocellular carcinoma.
    Wang XQ; Luk JM; Garcia-Barcelo M; Miao X; Leung PP; Ho DW; Cheung ST; Lam BY; Cheung CK; Wong AS; Lau SS; So MT; Yu WC; Cai Q; Liu KS; Hui CK; Lau GK; Poon RT; Wong J; Fan ST
    Clin Cancer Res; 2006 Sep; 12(17):5248-52. PubMed ID: 16951245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic polymorphisms in the Wnt/β-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Kim SS; Cho HJ; Lee HY; Park JH; Noh CK; Shin SJ; Lee KM; Yoo BM; Lee KJ; Cho SW; Cheong JY
    Clin Biochem; 2016 Jul; 49(10-11):792-801. PubMed ID: 26968103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WISP1 overexpression promotes proliferation and migration of human vascular smooth muscle cells via AKT signaling pathway.
    Lu S; Liu H; Lu L; Wan H; Lin Z; Qian K; Yao X; Chen Q; Liu W; Yan J; Liu Z
    Eur J Pharmacol; 2016 Oct; 788():90-97. PubMed ID: 27321870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of WISP1 as a novel oncogene in glioblastoma.
    Jing D; Zhang Q; Yu H; Zhao Y; Shen L
    Int J Oncol; 2017 Oct; 51(4):1261-1270. PubMed ID: 28902353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of CCN family members correlates with the clinical features of hepatocellular carcinoma.
    Zhang H; Li W; Huang P; Lin L; Ye H; Lin D; Koeffler HP; Wang J; Yin D
    Oncol Rep; 2015 Mar; 33(3):1481-92. PubMed ID: 25571929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TNIP1 Polymorphisms with the Risk of Hepatocellular Carcinoma Based on Chronic Hepatitis B Infection in Chinese Han Population.
    Cheng Y; Jiang X; Jin J; Luo X; Chen W; Li Q; Zhang C
    Biochem Genet; 2019 Feb; 57(1):117-128. PubMed ID: 30073579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serpin peptidase inhibitor (SERPINB5) haplotypes are associated with susceptibility to hepatocellular carcinoma.
    Yang SF; Yeh CB; Chou YE; Lee HL; Liu YF
    Sci Rep; 2016 May; 6():26605. PubMed ID: 27221742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic polymorphisms of proangiogenic factors seem to favor hepatocellular carcinoma development in alcoholic cirrhosis.
    Machado MV; Janeiro A; Miltenberger-Miltenyi G; Cortez-Pinto H
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):438-43. PubMed ID: 24445728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C.
    Kato N; Ji G; Wang Y; Baba M; Hoshida Y; Otsuka M; Taniguchi H; Moriyama M; Dharel N; Goto T; Shao RX; Matsuura T; Ishii K; Shiina S; Kawabe T; Muramatsu M; Omata M
    Hepatology; 2005 Oct; 42(4):846-53. PubMed ID: 16175604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study on the relationship between single-nucleotide polymorphisms in IL-6, IL-10 genes and HBV-related hepatocellular carcinoma].
    Qiu XQ; Bei CH; Yu HP; Zeng XY; Zhong QA
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 May; 32(5):510-3. PubMed ID: 21569738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells.
    Cervello M; Giannitrapani L; Labbozzetta M; Notarbartolo M; D'Alessandro N; Lampiasi N; Azzolina A; Montalto G
    Ann N Y Acad Sci; 2004 Dec; 1028():432-9. PubMed ID: 15650268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between interleukin-21 gene polymorphisms (rs12508721) and HBV-related hepatocellular carcinoma.
    Zhang QX; Li SL; Yao YQ; Li TJ
    Int J Immunogenet; 2016 Jun; 43(3):151-8. PubMed ID: 27122304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. WISP 1 is an important survival factor in human mesenchymal stromal cells.
    Schlegelmilch K; Keller A; Zehe V; Hondke S; Schilling T; Jakob F; Klein-Hitpass L; Schütze N
    Gene; 2014 Nov; 551(2):243-54. PubMed ID: 25200494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The contribution of caveolin-1 genotype and phenotype to hepatocellular carcinoma.
    Hsu CM; Yang MD; Tsai CW; Ho CY; Chang WS; Chang SC; Jeng LB; Tsai Y; Tsai FJ; Bau DT
    Anticancer Res; 2013 Feb; 33(2):671-7. PubMed ID: 23393366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of Chitinase 3-Like 1 Single Nucleotide Polymorphisms with Hepatocellular Carcinoma in Taiwan.
    Huang WS; Lin HY; Yeh CB; Chen LY; Chou YE; Yang SF; Liu YF
    Int J Med Sci; 2017; 14(2):136-142. PubMed ID: 28260989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
    Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
    Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variations in DEPDC5 gene and its association with chronic hepatitis C virus infection in Saudi Arabia.
    Al-Anazi MR; Matou-Nasri S; Abdo AA; Sanai FM; Khan MQ; Albenmousa A; Al-Ashgar HI; Khalaf NZ; Al-Ahdal MN; Al-Qahtani AA
    BMC Infect Dis; 2014 Dec; 14():632. PubMed ID: 25551790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.